BioVille is part of a bigger network:
Beta-Cell NV reports the achievement of an important intermediate milestone in the generation of a xenogeneic off-the-shelf cell product for the treatment of diabetes
Company growth prompts Connected-Pathology relocation to larger laboratory facilities to accommodate increase in study capacity
Rejuvenate Biomed appoints life sciences leader Dr. Ajit Shetty as Chair of the Board of Directors to help guide international ambitions
Resident in the spotlight: Archer Research
This time we turn our sights to BioVille resident Archer Research, a "Contract Research Organization" (CRO). They help companies (industry) and healthcare professionals (researchers and physicians) with their clinical research for medical devices.
Rewind Therapeutics appoints Anja Harmeier, PhD, MBA, as Chief Executive Officer
Leuven, Belgium, 22 September 2021 – Rewind Therapeutics (“Rewind”), a private Belgian biotech company developing innovative first-in-class remyelinating therapies for multiple sclerosis and other myelin-related diseases, announces the appointment of Anja Harmeier, PhD, MBA, as Chief Executive Officer.
Resident in the spotlight: Flanders Vaccine
BioVille resident Flanders Vaccine is the umbrella organization within the vaccines and immunotherapy industry in Flanders. Their mission? Create a platform for industry stakeholders, stimulate innovation, and - if possible - accelerate breakthroughs.
Thema Group specializes in recruitment within the Life Sciences industry
30 years of experience, 20+ employees, 4 offices and a presence in 3 countries: the credentials that Thema Group puts forward are impressive. Despite the challenges of the past year - Corona, ring a bell... - the Life Sciences recruitment agency still shows its fighting spirit. "We’re in a strong place and remain committed to growth. We’re setting up Thema Group France before the end of the year."
FOx BIOSYSTEMS launches the White FOx, its new generation biosensor with fiber-optic surface plasmon resonance
FOx BIOSYSTEMS today announced the launch of their novel biosensor, the White FOx. Through recent collaborations with scientists and engineers, on a range of EU projects, FOx BIOSYSTEMS have created a robust, low maintenance, easy-to-use instrument capable of delivering precise results in real time.
Complix signs Global Drug Discovery and Development Agreement with I-Mab to develop cell penetrating Alphabodies against two intracellular Immuno-oncology targets
Complix, a biopharmaceutical company developing a pipeline of transformative Alphabody therapeutics announces that it has signed a significant drug discovery deal with I-Mab (Nasdaq: IMAB), an innovation-driven clinical stage biopharmaceutical company committed to the discovery, development and commercialization of novel and highly differentiated biologics in the immuno-oncology therapeutic area.
Archer Research proud member of BeCRO
Resident Archer Research is now a member of BeCRO (Belgian Association of Contract Research Organisations). Archer Research is in fact the first member fully specialized in the Medical Device Industry to join this association.
Countering the disposable culture in the healthcare industry
REPOMED wants to put a stop to the disposable culture in the healthcare industry. "Today, the majority of medical waste goes into the incinerator.”